间歇性禁食对2型糖尿病血糖控制影响的meta分析和meta回归：亚组分析和变异性。

IF 3.4 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes & Metabolic Syndrome-Clinical Research & Reviews Pub Date : 2025-07-01 DOI:10.1016/j.dsx.2025.103279

Mila Desi Anasanti , Nasir Hamzah

{"title":"间歇性禁食对2型糖尿病血糖控制影响的meta分析和meta回归：亚组分析和变异性。","authors":"Mila Desi Anasanti , Nasir Hamzah","doi":"10.1016/j.dsx.2025.103279","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>To assess the effects of intermittent fasting (IF) on glycaemic control in people with type 2 diabetes (T2D), using meta-analysis and meta-regression.</div></div><div><h3>Methods</h3><div>We systematically reviewed and analyzed studies evaluating IF regimens, including time-restricted eating, alternate-day fasting, and periodic fasting. Outcomes assessed were HbA1c and fasting glucose. Subgroup and interaction analyses explored effects of BMI, age, sex, adherence, and IF type.</div></div><div><h3>Results</h3><div>Seventeen studies (n = 1169) were included. IF significantly improved glycaemic control (SMD: 0.84; 95 % CI: 0.45–1.22, p < 0.001). Subgroups with higher BMI and adherence showed greater improvements. Time-restricted eating yielded the largest effect sizes. No significant moderation by age, sex, or study duration was found.</div></div><div><h3>Conclusion</h3><div>IF is effective for improving blood glucose in T2D, particularly with high adherence and in people with obesity. Standardizing IF protocols and improving adherence could enhance future interventions.</div></div>","PeriodicalId":48252,"journal":{"name":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","volume":"19 7","pages":"Article 103279"},"PeriodicalIF":3.4000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Meta-analysis and meta-regression of intermittent fasting effects on glycaemic control in type 2 diabetes: Subgroup analyses and variability\",\"authors\":\"Mila Desi Anasanti , Nasir Hamzah\",\"doi\":\"10.1016/j.dsx.2025.103279\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><div>To assess the effects of intermittent fasting (IF) on glycaemic control in people with type 2 diabetes (T2D), using meta-analysis and meta-regression.</div></div><div><h3>Methods</h3><div>We systematically reviewed and analyzed studies evaluating IF regimens, including time-restricted eating, alternate-day fasting, and periodic fasting. Outcomes assessed were HbA1c and fasting glucose. Subgroup and interaction analyses explored effects of BMI, age, sex, adherence, and IF type.</div></div><div><h3>Results</h3><div>Seventeen studies (n = 1169) were included. IF significantly improved glycaemic control (SMD: 0.84; 95 % CI: 0.45–1.22, p < 0.001). Subgroups with higher BMI and adherence showed greater improvements. Time-restricted eating yielded the largest effect sizes. No significant moderation by age, sex, or study duration was found.</div></div><div><h3>Conclusion</h3><div>IF is effective for improving blood glucose in T2D, particularly with high adherence and in people with obesity. Standardizing IF protocols and improving adherence could enhance future interventions.</div></div>\",\"PeriodicalId\":48252,\"journal\":{\"name\":\"Diabetes & Metabolic Syndrome-Clinical Research & Reviews\",\"volume\":\"19 7\",\"pages\":\"Article 103279\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes & Metabolic Syndrome-Clinical Research & Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1871402125000967\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871402125000967","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

目的：通过meta分析和meta回归，评估间歇性禁食（IF）对2型糖尿病（T2D）患者血糖控制的影响。方法：我们系统地回顾和分析了评估IF方案的研究，包括限时进食、隔日禁食和周期性禁食。评估的结果是HbA1c和空腹血糖。亚组和相互作用分析探讨了BMI、年龄、性别、依从性和IF类型的影响。结果：纳入17项研究（n = 1169）。IF可显著改善血糖控制（SMD: 0.84; 95% CI: 0.45-1.22, p）结论：IF可有效改善t2dm患者的血糖，尤其是高依从性患者和肥胖患者。标准化IF方案和提高依从性可以加强未来的干预措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Meta-analysis and meta-regression of intermittent fasting effects on glycaemic control in type 2 diabetes: Subgroup analyses and variability

Aims

To assess the effects of intermittent fasting (IF) on glycaemic control in people with type 2 diabetes (T2D), using meta-analysis and meta-regression.

Methods

We systematically reviewed and analyzed studies evaluating IF regimens, including time-restricted eating, alternate-day fasting, and periodic fasting. Outcomes assessed were HbA1c and fasting glucose. Subgroup and interaction analyses explored effects of BMI, age, sex, adherence, and IF type.

Results

Seventeen studies (n = 1169) were included. IF significantly improved glycaemic control (SMD: 0.84; 95 % CI: 0.45–1.22, p < 0.001). Subgroups with higher BMI and adherence showed greater improvements. Time-restricted eating yielded the largest effect sizes. No significant moderation by age, sex, or study duration was found.

Conclusion

IF is effective for improving blood glucose in T2D, particularly with high adherence and in people with obesity. Standardizing IF protocols and improving adherence could enhance future interventions.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Diabetes & Metabolic Syndrome-Clinical Research & Reviews ENDOCRINOLOGY & METABOLISM-

CiteScore

22.90

自引率

2.00%

发文量

248

审稿时长

51 days

期刊介绍： Diabetes and Metabolic Syndrome: Clinical Research and Reviews is the official journal of DiabetesIndia. It aims to provide a global platform for healthcare professionals, diabetes educators, and other stakeholders to submit their research on diabetes care. Types of Publications: Diabetes and Metabolic Syndrome: Clinical Research and Reviews publishes peer-reviewed original articles, reviews, short communications, case reports, letters to the Editor, and expert comments. Reviews and mini-reviews are particularly welcomed for areas within endocrinology undergoing rapid changes.